Send a text

Weight loss drugs are changing what’s medically possible, but are they changing what we expect from bodies too? In this episode, we unpack obesity, GLP-1 drugs like Ozempic and Wegovy, and the tension between public health and fatphobia. We discuss whether these medications address a global health crisis, or if they are just reshaping weight stigma with better branding. 

Enjoyed the episode? Please leave a like, comment or subscribe :) 

Key sources:

1. World Health Organization (2024). Obesity and Overweight.
   https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
2. Ryan et al. (2023). Weight stigma experienced by patients with obesity in healthcare settings: A qualitative evidence synthesis.
   https://onlinelibrary.wiley.com/doi/10.1111/obr.13606
3. Heitmann (2025). The Impact of Novel Medications for Obesity on Weight Stigma and Societal Attitudes: A Narrative Review. 
   https://pmc.ncbi.nlm.nih.gov/articles/PMC11799028/

McWhorter, K. L. (2020). Obesity Acceptance: Body Positivity and Clinical Risk Factors. https://www.intechopen.com/chapters/73236 

Support the show

Follow us on our socials so you don’t miss anything!

• Instagram https://www.instagram.com/whi_podcast/
• Tiktok https://www.tiktok.com/@whi_podcast?_t=8cw9TYkj5XG&_r=1
• Twitter https://mobile.twitter.com/whi_podcast
• Facebook https://www.facebook.com/WHIpodcast
• LinkedIn ...